Your browser doesn't support javascript.
loading
High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer.
Evans, D Gareth; van Veen, Elke Maria; Byers, Helen J; Evans, Sarah J; Burghel, George J; Woodward, Emma Roisin; Harkness, Elaine F; Eccles, Diana M; Greville-Haygate, Stephanie L; Ellingford, Jamie M; Bowers, Naomi L; Pereira, Marta; Wallace, Andrew J; Howell, Sasha J; Howell, Anthony; Lalloo, Fiona; Newman, William G; Smith, Miriam Jane.
Affiliation
  • Evans DG; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK gareth.evans@mft.nhs.uk.
  • van Veen EM; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Byers HJ; Prevent Breast Cancer Centre, Wythenshawe Hospital Manchester, University NHS Foundation Trust, Manchester, UK.
  • Evans SJ; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Burghel GJ; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Woodward ER; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Harkness EF; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Eccles DM; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Greville-Haygate SL; Department of Histopathology, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
  • Ellingford JM; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Bowers NL; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Pereira M; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Wallace AJ; Prevent Breast Cancer Centre, Wythenshawe Hospital Manchester, University NHS Foundation Trust, Manchester, UK.
  • Howell SJ; Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Howell A; University of Southampton and University Hospital Southampton, Southampton, UK.
  • Lalloo F; University of Southampton and University Hospital Southampton, Southampton, UK.
  • Newman WG; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Smith MJ; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
J Med Genet ; 59(2): 115-121, 2022 02.
Article de En | MEDLINE | ID: mdl-33758026
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Gène BRCA1 / Gène BRCA2 / Checkpoint kinase 2 / Mutation Type d'étude: Diagnostic_studies / Observational_studies / Risk_factors_studies Limites: Adult / Female / Humans Langue: En Journal: J Med Genet Année: 2022 Type de document: Article Pays d'affiliation: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Gène BRCA1 / Gène BRCA2 / Checkpoint kinase 2 / Mutation Type d'étude: Diagnostic_studies / Observational_studies / Risk_factors_studies Limites: Adult / Female / Humans Langue: En Journal: J Med Genet Année: 2022 Type de document: Article Pays d'affiliation: Royaume-Uni